Olema Oncology
San Francisco, United States· Est. 2006
Olema Oncology is a clinical-stage biopharmaceutical company developing novel therapies to transform treatment for metastatic breast cancer and beyond.
Private Company
Total funding raised: $466.8M
About
Olema Oncology is a clinical-stage biopharmaceutical company developing novel therapies to transform treatment for metastatic breast cancer and beyond.
Small Molecules
Funding History
4Total raised:$466.8M
PIPE$150MMar 15, 2023
IPO$204.8MJan 8, 2021
Series B$85MJul 15, 2020
Series A$27MMay 15, 2019